Aims & Scope
Innovation & Impact is an interdisciplinary Scientific Technology and Business journal presenting high profile invited papers, case studies and perspective papers concerning the process of innovation and its impact on society and market.
We are truly excited about the moment, when research exerts an impact on our lives. This process happens on frontiers of academic research and business with involvement of many parties: technology transfer offices, universities, companies, venture capital, business angels, science parks, incubators etc.
The aim of the journal is to deliver the platform for communication between all of them and across ecosystems. Journal presents a mixture of quality research papers and exciting stories of companies and tech transfer.
Journal accepts the following types of submissions:
- Opening papers presenting systematic studies regarding issues related to the process of innovation. Each issue contains one opening paper devoted to ecosystem or sector described in the issue and written by invited author.
- Case studies presenting inspiring examples of innovation. In particular, the journal focuses on presenting route of scientific idea to the market. It also contains articles describing framework or institution that is supporting the process of technology transfer.
- Perspective papers presenting systematic studies regarding issues related to the process of innovation. Perspective papers are devoted to particular elements associated with the journal topics.
Our story made short
Initially Innovation & Impact was intended to be a classic scientific journal with the ambition of drawing the attention of all stakeholders involved in the process of innovation. We soon realized that this aim cannot be fulfilled in this way. A new approach was required to address different writing and reading habits of scientists, entrepreneurs and investors. After a number brainstorms, discussions and pivots the journal formula ended in the place which in our belief is a perfect ratio between scientific merit, practicality and impact.
Each issue combines an opening and perspective papers (which deliver professional and scientific discussion) with a number of case studies (which deliver inspiring and practical examples).
Prof Alan Barrell
Alan has worked in Health Care and Medical Research, as Chairman and Chief Executive of large multi-national companies and smaller technology start-ups. He teaches in Universities in UK, Europe, North America and Asia with Professorships in European and Chinese Universities. He has raised and managed a Venture Capital Fund, is a Business Angel Investor and Trustee of charities including Chairmanship of the Cambridge Rare Diseases Network. He has been honoured with The Queen’s Award for Enterprise Promotion in the UK and with membership as Knight First Class of the Order of the White Rose of Finland for services to Education. His current work is focussed on the commercialisation of research, technology start-ups and the development of UK-China Trade and international relationships more generally. Alan promotes the vision of “A World Without Borders”. His career experience has prepared him well to be Chairman of Cambridge Learning Gateway.
email@example.com 00 44 (0) 1223 416466 0044 (0) 788 7644597 www.camlg.com
Dr Grzegorz Liskiewicz
Researcher, entrepreneur, science popularizer. He works at the Institute of Turbomachinery, Lodz University of technology. He is working on the design and safety of centrifugal compressors with the goal to make industrial compressors safer and more economic. He graduated his PhD from University of Strathclyde, and visited University of Oxford, Cambridge, Leeds. Grzegorz serves as the Rector’s Proxy for Academic Entrepreneurship, and board of directors member in the University Technology Transfer Center ltd. In years 2018-2020 Grzegorz served as the board of directors member in the Top 500 Innovators Association Poland. In 2011 Grzegorz co-funded ACADEMYA, company providing solutions for polish authors of research papers. Nowadays, the company is a polish leader in the field.
Lodz University of Technology, Wolczanska 219/223, 90 – 924 Lodz, Poland. Email: firstname.lastname@example.org
Prof Barbara Jachimska
Associate Professor at the Jerzy Haber Institute of Catalysis and Surface Chemistry, Polish Academy of Sciences. She has M.Sc. in Material Engineering and Ceramic and M.Sc. in Environmental Protection from AGH University of Science and Technology. She holds a Ph.D. with honours in chemistry and Doctor of Sciences (habilitation) both received from Jerzy Haber Institute of Catalysis and Surface Chemistry in 2001 and 2012, respectively. Barbara Jachimska works in the area of polymers, proteins and the assembly behaviour of biopolymers, especially study adsorption, adhesion and interfacial phenomena in the nano-colloidal system. She had many internships abroad, among others in Germany, France, China, and the UK. She participated in the implementation of tens of research projects. The results of her study were presented at many international conferences, and she is co-author more than 70 articles published in international journals. In 2015 was awarded the scholarship from Polish Ministry of Education “TOP 500 innovators” program organized jointly by the University of Cambridge Enterprise and Oxentia (Oxford University). Organizer of many international conferences and workshops, and co-organizer of events devoted to technological innovation. Expert in the Regional Operational Programme of the Malopolska Region for 2014- 2020 Regional intelligence Specialization (RIS): Life Sciences, Chemistry.
Jerzy Haber Institute of Catalysis and Surface Chemistry, Polish Academy of Sciences, Niezapominajek 8, 30-239 Krakow, Poland. Email: email@example.com
Dr Karolina Zapadka
Head of Babraham Accelerator at Babraham Research Campus. Karolina joined the Babraham Research Campus in 2018 where she co-founded and successfully delivered the Accelerate@Babraham initiative. As part of the initiative, Karolina launched the first life science acceleration programme for early stage ventures combining access to lab space, mentoring from business and scientific experts and access to investors in the Cambridge Cluster. Karolina’s strong interest in life science entrepreneurship and expediting treatment to patients motivated her to join the Oxbridge Biotech Roundtable in 2013 where she launched the OneStart competition. She then co-founded and became Chief of Staff at the Global Innovation Forum and IMAGINE IF! accelerator in 2014. This experience enabled her to develop strong relationships with various partners regionally, nationally and internationally – including investors, academic leaders, senior managers and CEO’s of biotech and big pharmaceutical companies. Karolina has over 7 years experience in building healthcare companies within the Cambridge Cluster. She played a pivotal role in securing over £8.5 million for a number of British early stage ventures (pre-seed and seed stage) from a stellar syndicate of investors (business angels and VCs). She started her career as a scientist in protein and peptide therapeutics at a leading biopharmaceutical company developing a portfolio of products to enable improved treatments for diabetes care. Karolina completed a PhD in Biophysics at the University of Cambridge and carried out her Postdoctoral work at AstraZeneca (MedImmune).
Babraham Research Campus, Babraham Hall, Babraham, Cambridge CB22 3AT Email: firstname.lastname@example.org
Dr Rabab Nasrallah
Investment analyst with Earlybird Venture Capital based in Germany, with a major focus on investments in the health care space. Prior to this role, Rabab was the program manager for the INCUBATE accelerator based at the University of Sydney, Australia. With an extensive research background, Rabab has held roles in leading global research organisations in Australia and the UK, including The George Institute for global health, Lowy Cancer Research Centre, Cancer Research UK, and Cambridge University.
Rabab has a PhD in regenerative medicine from UNSW, Australia. Following her postdoctoral fellowship at the Babraham Institute, Cambridge, she published a first author Nature paper in 2020.
Zoë Callister-Hakewill is General Manager of Dr’s On Call, a mobile medical practice that supports the needs of vulnerable populations in greater Sydney, and a Research Officer in the Macquarie University Department of Cognitive Science. Zoë oversees the digital transformation of the practice, and led the development of digital health policies and training to support a team of medical professionals to deliver quality clinical care through digital health.
Zoë has expertise in the fields of public health, health law and ethics. She holds a Bachelor of Medical Science, a Masters of International Public Health, and a Masters of Health Law from the University of Sydney, and is completing a Bachelor of Psychology (Honours) at Macquarie University. At the Macquarie University Department of Cognitive Science, she is part of a research group using mobile EEG technology to investigate brain health. She recently attained an Executive Ready scholarship with Women in Leadership Australia.
Luca grew up in Padua (Italy), when in 2012 decided to move to Lodz (Poland) to study Engineering. Ended up with two BSc (Applied Physics and Bioengineering), after which he moved to Heidelberg (Germany), to earn a MSc in physics, and then moved back to Poland to start the doctoral school in physics, which is still ongoing. Throughout the studies, he supported himself financially working in IT (even nowadays), in many different settings, and still unsure what exactly will do in the future.
His hobbies are playing with applications of IT in other fields, especially in physics, finance, and economics, playing guitar, and reading English and Polish literature books. Enjoys regular physical activity in calisthenics and running. Personality type INTP-T.
Lodz University of Technology, Email: email@example.com
Magdalena Szota is a PhD student at the Jerzy Haber Institute of Catalysis and Surface Chemistry PAS. She graduated from the Krakow University of Technology in the field of biotechnology. In her master’s thesis, she worked on Controlled Drug Delivery Systems (CDDS). Currently, she is preparing a doctoral dissertation in the field of nanotechnology. Its main research areas are the physicochemistry of colloidal systems, particularly the physicochemical characteristics of dendrimers and proteins in the context of their interactions with anticancer drugs.
Jerzy Haber Institute of Catalysis and Surface Chemistry, Polish Academy of Sciences, Niezapominajek 8, 30-239 Krakow, Poland. Email: firstname.lastname@example.org
Dr Fatima Nasrallah
Dr. Fatima Nasrallah is a neuroscientist with a background in magnetic resonance and interdisciplinary brain research. She graduated with a PhD in Nuclear Magnetic Resonance from the University of New South Wales in 2009. Her program of research spans basic and clinical science where she has pioneered the developement of Magnetic Resonance Imaging methods for clinical translation, specifically the development of biomarkers for diagnostic and prognostic purposes in heath and injury. Her professional leadership manifests in leading a nationwide, multi-institutional trial for improving outcome in patients with traumatic brain injury forging multidisciplinary collaborations in healthcare, industry, and academia as the key to future healthcare developments.
Journal Advisory Board
An expert in the design, development and marketing of services and the management of innovation, he has developed tools, process and services that help organisations go to market more effectively and efficiently. At IBM, Nicholas was Director of Channels and Business Partner Management, EMEA, with a revenue of >$3bn of sales via business partners and then Vice President, Global Distribution Channel Strategy. This responsibility included the development and application of the methods and processes used by the brands, known as Routes to Market, to reach and support customers via the network of 48,000 business partners. His team grew sales via distribution channels to over $4bn. He has undertaken a number of assignments in service design, innovation management, strategy development, performance management, segmentation, impact estimation, customer experience design, optimisation modelling and prioritisation of objectives. He helped design the two year masters course in service design at the Royal College of Art (RCA) and is a visiting tutor for this course. He is a Visiting Lecturer at Universitat Politèchnica de Catalunya, Imperial College, Imperial College Business School, Royal College of Art, Ecole Supérieure of Advanced Industrial Technologies (ESTIA), Aalto University, University of Tampere. He works with ETICoop in France which has created 160 startups since 2013 and as a member of the Innovation Advisory Board of UNLEASH – a global innovation lab which gathers top talents to collaborate on solutions that help meet the United Nations Sustainable Development Goals. Over the past fifteen years he has been closely involved as a coach, mentor or subject matter expert in over 200 startups. He is also a member of the committee of the Society of Projectics: the science of projects addressing complexity in systems and organisations; and an editor of the Journal of Projectics. He has a masters in economics, from King’s College, Cambridge and has interests in several early stage companies developing innovative products and services, including Claned, Plumis, Repindex, Smartology and Waratek.
David Gill is Managing Director of the St John’s Innovation Centre in Cambridge. He previously set up and ran the Innovation & Technology Unit at HSBC Bank in London, then served as an executive director of a venture fund focused on early-stage, technology-based investments. Educated at Cambridge, he was called to the Bar by the Middle Temple before working in corporate finance for US and UK banks. A Sloan Fellow at the Stanford Graduate School of Business in California (2004-05), David is currently an Academic Collaborator at the University of Cambridge Institute for Manufacturing and non-executive director several start-up companies. David is the co-author of numerous publications on innovation, incubation and finance. St John’s Innovation Centre is a 6000 m2 technology business incubator (established by St John’s College, University of Cambridge, in 1987) and home to some 85 high-growth firms. St John’s is a Business Innovation Centre (BIC) accredited by the European Business Network and a partner in the Enterprise Europe Network.
People we would like to acknowledge
There are many people that supported Innovation & Impact in key moments. We would like to acknowledge them here and express our gratitude.
- David Gill – the idea of journal appeared on his workshop and he presented an immediate support that is with us all the time.
- Nathan Pike – the journal title appeared in our brainstorm.
- Magdalena Zapadka – for a wonderful design of journal covers.